News

The county joins municipalities across the country suing Eli Lilly, CVS Caremark, and others for sky-high prices.
In study after study, injected GLP-1 weight loss medications appear to work better on average for women than they do for men.
Federal regulators have accepted Novo Nordisk’s application to produce a pill version of its injectable weight-loss ...
Eli Lilly & Co.’s stock soared 14% Thursday, to put it on track for its biggest one-day gain in about 25 years, after the drugmaker reported positive results from a late-stage trial of a GLP-1 ...
The bill would place Nevada among the 26 states, including Kentucky and New Mexico, that have already set limits on the price ...
Novo Nordisk A/S' Q1 earnings reveal strong growth in semaglutide-driven sales despite a slight revenue miss. Learn more ...
Eli Lilly’s (NYSE:LLY) stock faced a notable decline following the company’s announcement of a reduced profit forecast, despite delivering first-quarter results that surpassed Wall Street ...
Thank you for joining us for Eli Lilly ... U.S. was at 35 in Ireland was a whatever, 15. So I think tax reform is key to that, and we'll fix that problem for the long term. Within Lilly, we ...
Eli Lilly said the revision reflects a $1.57 billion deal charge recorded in the first quarter, which is primarily related to its acquisition of a certain oral cancer drug from Scorpion Therapeutics.
as is the case with Eli Lilly (NYSE: LLY). It is the most valuable healthcare company in the world, with a market cap of around $800 billion. And yet it may still not be too late to invest in it.